Overview

Paricalcitol Over Inflammatory Parameters on Chronical Kidney Disease Patients

Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
Use of Paricalcitol in stage Vd Chronic Kidney Disease patients, over the effect of inflammatory and oxidative stress parameters.
Phase:
Phase 3
Details
Lead Sponsor:
Ricardo Mouzo Mirco
Treatments:
Atorvastatin
Atorvastatin Calcium
Ergocalciferols